BVGH’s AAI Palliative Care Digital Training Program (English), which attracted 1,816 attendees from 34 African countries, concluded in November 2023. Upon popular demand and participant feedback, BVGH organized two workshops for AAI hospital partners to practice the communication strategies that they learned during the digital training. The workshops, which covered breaking bad news and communicatingContinue reading “AAI Hospital Partners Practice Palliative Care Communication Strategies”
Author Archives: bvghseattle
Kenyan Pharmacists Strengthen Their Oncology Pharmacy Skills
Dr. Nancy Guo (left) and Dr. Alexandre Chan (right) review the course structure with participants Following its 2023 AAI Oncology Pharmacy Digital Lecture Series, BVGH held an on-site training program in Kenya to build upon the digital training topics and refine attendees’ oncology pharmacy knowledge and skills. Held at Kenyatta National Hospital (KNH), the AAIContinue reading “Kenyan Pharmacists Strengthen Their Oncology Pharmacy Skills”
Francophone Clinicians Build Palliative Care Knowledge and Confidence
Through its English-language AAI Palliative Care digital training program, BVGH equipped nearly 2,000 healthcare providers around the world with newfound skills and knowledge to enhance the quality of life of cancer patients, especially those with late-stage disease. Building upon the successes of the English course and leveraging the Palliative Care Interdisciplinary Curriculum, BVGH led aContinue reading “Francophone Clinicians Build Palliative Care Knowledge and Confidence”
Closing the Cancer Care Gap in Africa
Cancer in AfricaAfrica and other low- and middle-income regions are collectively responsible for 70% of the global cancer burden. Africa faces a 67% mortality-to-incidence ratio from cancer according to recent statistics released by the World Health Organization’s International Agency for Research on Cancer (IARC). Compare this number to the 23% touted by Northern America, andContinue reading “Closing the Cancer Care Gap in Africa”
Highlighting the Essential Role of the Oncology Pharmacist
The oncology pharmacy team’s pivotal position in the multidisciplinary management of cancer patients cannot be understated. The oncology pharmacist is responsible for patient care through preparing and delivering cancer medicines, creating a safe workplace to handle hazardous materials, and ensuring overall patient safety. Healthcare leaders across Africa expressed to BVGH their concern over a lackContinue reading “Highlighting the Essential Role of the Oncology Pharmacist”
Equipping Pathologists with Advanced Expertise
Accurate and timely diagnosis plays a key role in ensuring successful cancer treatment outcomes. This past December, BVGH concluded its 2023 AAI Cancer Pathology Digital Training, a six-session course covering the fundamentals of breast, brain, ocular, and skin cancer pathology. These topics were requested by participants of past AAI programs. Expert trainers from Harvard, Stanford, andContinue reading “Equipping Pathologists with Advanced Expertise”
Cameroon ICU Nursing Team Engages in Virtual Mentorship
From left to right: Ms. Becca deDufour (BSN, RN, CCRN, Memorial Sloan Kettering Cancer Center), Nurse Grace NTIMEU KEPNDEP (Lead ICU Nurse, Mbingo Baptist Hospital), Dr. David Sunday (Lead ICU Physician, Mbingo Baptist Hospital), Ms. Joanna Tomicich (DNP, NP-C, AGACNP-BC, FCCM, Memorial Sloan Kettering Cancer Center) Recognizing that the Intensive Care Unit (ICU) nursing teamContinue reading “Cameroon ICU Nursing Team Engages in Virtual Mentorship”
Researchers in Germany and Nigeria Join Forces to Differentiate Febrile Diseases with New Diagnostics
In sub-Saharan Africa and other regions with high burdens of malaria, patients presenting with fevers are often prescribed antimalarial drugs without a confirmed diagnosis to avoid treatment delays. However, many infectious diseases cause fevers, and inappropriate use of antimalarial medicines for patients who do not have malaria fuels development of drug resistance. While malaria diagnosticContinue reading “Researchers in Germany and Nigeria Join Forces to Differentiate Febrile Diseases with New Diagnostics”
Network for Africa’s Clinical Trials Community Established
BVGH is thrilled to be part of the Clinical Trials Community Africa Network project, a bold step towards a coordinated and sustainable clinical trials network in Africa. This joint effort with Global Health EDCTP; Science for Africa Foundation; Fondation Mérieux; Medicines Development for Global Health; The Janssen Pharmaceutical Companies of Johnson & Johnson; and nuvoteQ.io aims to amplify the capacity of African trial sites and laboratories, while providing essential data and regulatory information through the Clinical Trials Community platform. Together, we can bring life-changing treatments to those who need them most. BVGH will support site and laboratory network development; coordinate and implement capacity building programs; and develop and disseminate targeted communications materials to raise visibility.
NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres [EXTERNAL VIDEO]
In this interview with eCancer, the CEO of the Nigeria Sovereign Investment Authority (NSIA), Aminu Umar-Sadiq, discusses the work of NSIA with building new cancer centers in Nigeria. Watch the video here.